Susan Quinn DeJoy

Studies Evaluating the Antitumor Activity and Toxicity of Interleukin-15, a New T Cell Growth Factor: Comparison with Interleukin-2

William E. Munger, Susan Quinn DeJoy, Robert Jeyaseelan et al. · Cellular Immunology · 1995 · 203 citations

Life Sciences, Immunology, Oncology +14

Selective immunomodulation by the antineoplastic agent mitoxantrone. I. Suppression of B lymphocyte function.

John M. Fidler, Susan Quinn DeJoy, J J Gibbons · The Journal of Immunology · 1986 · 124 citations · Full text

Life Sciences, Immunology, Pharmacology +14

Selective immunomodulation by the antineoplastic agent mitoxantrone. II. Nonspecific adherent suppressor cells derived from mitoxantrone-treated mice.

John M. Fidler, Susan Quinn DeJoy, F R Smith et al. · The Journal of Immunology · 1986 · 109 citations · Full text

Life Sciences, Immunology, Pharmacology +12

Streptococcal cell wall arthritis. Passive transfer of disease with a T cell line and crossreactivity of streptococcal cell wall antigens with Mycobacterium tuberculosis.

Susan Quinn DeJoy, Kim M. Ferguson, Theresa M. Sapp et al. · The Journal of Experimental Medicine · 1989 · 57 citations · Full text

Life Sciences, Immunology, Pathology +13

Design and Synthesis of Novel Diaminoquinazolines with <i>in Vivo</i> Efficacy for β-Catenin/T-Cell Transcriptional Factor 4 Pathway Inhibition

Christoph M. Dehnhardt, Aranapakam M. Venkatesan, Zecheng Chen et al. · Journal of Medicinal Chemistry · 2009 · 31 citations

Pharmacy, Medicinal Chemistry, Pharmacology +12